Highlights and Quick Summary
- Equity Repurchase (Preffered, Net) for the quarter ending September 30, 2019 was $10 Million
- Annual Equity Repurchase (Preffered, Net) for 2019 was $10 Million
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Preffered, Net) of Biodesix, Inc.
Most recent Equity Repurchase (Preffered, Net)of BDSX including historical data for past 10 years.Interactive Chart of Equity Repurchase (Preffered, Net) of Biodesix, Inc.
Biodesix, Inc. Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2019 | $10.0 | – | – | – | $10.0 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research